构建医保药品价格谈判机制的研究  

A Study on Building the Medical Insurance Price Negotiation Mechanism

作　　者：张海涛[1,2] 

机构地区：[1]苏州大学政治与公共管理学院 [2]南京审计大学国家治理与国家审计研究院

出　　处：《价格理论与实践》2017年第10期52-55,共4页Price:Theory & Practice

摘　　要：我国对国家药品价格谈判机制的构建尚处在探索阶段,存在着谈判价格机制设定缺乏客观依据、谈判流程尚不成熟等问题。通过对比德、法、澳等国药品价格谈判模式,本文作者提出保障机制运作的协调性和可持续性是今后一段时间内价格谈判机制的完善方向,对此建议我国医保药品价格谈判应充分考虑药品价值与创新性,做好谈判后的对接工作,建立专业评价机构,确保谈判机制的协调高效可持续运作。China＇s medical insurance price negotiation mechanism is still in the explorato- ry stage, showing some problems, such as the lack of objective pricing of negotiated pricing,the negotiation process is not mature. This paper analyzes the characteristics of the international international negotiating mechanism of Germany, France and Australia, and finds out that the future development of the price negotiation mechanism is to ensure the coordination and sustainability of the operation of the guarantee mechanism. It is suggested that China＇s medical insurance price negotiation mechanism should pay more attention to the value and innovation of drugs, improve the docking work after negotiation and establish a professional drug economic evaluation institution.

关 键 词：药品价格改革 医保药品 药品价格谈判机制 创新药 药品可及性 

分 类 号：R95[医药卫生—药学]